Related Experiment Videos
Pharmacovigilance and pharmacogenetic discussions at WorldPharma 2010
Gordon Mallarkey1, Arduino A Mangoni2
1Sage Publications Ltd, 1 Oliver's Yard, 55 City Road, London EC1Y 1SP, UK.
Therapeutic Advances in Drug Safety
|August 2, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Structure- and Ligand-Based Discovery of Novel Non-Arginine-Based DDAH1 Inhibitors with Anti-Triple-Negative Breast Cancer Activity.
ACS medicinal chemistry letters·2026
A systematic review and meta-analysis of the systemic immune-inflammation index (SII) in rheumatic diseases.
Frontiers in immunology·2026
DDAH1 and DDAH2 drive vasculogenic mimicry and more aggressive phenotypes in triple negative breast cancer cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Factors associated with medication administration errors in hospitalized pediatric patients: A scoping review.
Therapeutic advances in drug safety·2026
An assessment of medication errors and associated factors to strengthen patient safety practices in a tertiary hospital in Cameroon.
Therapeutic advances in drug safety·2026
Development and validation of a MedDRA-based signal detection construct for drug-induced neurobehavioral impairment.
Therapeutic advances in drug safety·2026
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database.
Therapeutic advances in drug safety·2026
Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data.
Therapeutic advances in drug safety·2026